RDY Cash And Equivalents from 2010 to 2024

RDY Stock  USD 74.55  0.53  0.72%   
Dr Reddys Cash And Equivalents yearly trend continues to be fairly stable with very little volatility. Cash And Equivalents is likely to outpace its year average in 2024. During the period from 2010 to 2024, Dr Reddys Cash And Equivalents regression line of annual values had r-squared of  0.08 and arithmetic mean of  1,856,344,000. View All Fundamentals
 
Cash And Equivalents  
First Reported
2010-12-31
Previous Quarter
2.6 B
Current Value
2.8 B
Quarterly Volatility
1.1 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RDY main balance sheet or income statement drivers, such as Interest Expense of 1.7 B, Total Revenue of 296.9 B or Gross Profit of 245.1 B, as well as many exotic indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0055 or PTB Ratio of 4.2. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
This module can also supplement Dr Reddys' financial leverage analysis and stock options assessment as well as various Dr Reddys Technical models . Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Cash And Equivalents Growth Pattern

Below is the plot of the Cash And Equivalents of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Cash And Equivalents historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.93 B10 Years Trend
Pretty Stable
   Cash And Equivalents   
       Timeline  

RDY Cash And Equivalents Regression Statistics

Arithmetic Mean1,856,344,000
Geometric Mean1,109,583,282
Coefficient Of Variation61.64
Mean Deviation1,020,229,333
Median2,555,000,000
Standard Deviation1,144,281,933
Sample Variance1309381.1T
Range2.9B
R-Value(0.28)
Mean Square Error1298833.9T
R-Squared0.08
Significance0.31
Slope(71,875,286)
Total Sum of Squares18331336T

RDY Cash And Equivalents History

20242.8 B
20232.6 B
20222.9 B
202175 M
2020316 M
2019118 M
2018111 M

About Dr Reddys Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dr Reddys income statement, its balance sheet, and the statement of cash flows. Dr Reddys investors use historical funamental indicators, such as Dr Reddys's Cash And Equivalents, to determine how well the company is positioned to perform in the future. Although Dr Reddys investors may use each financial statement separately, they are all related. The changes in Dr Reddys's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dr Reddys's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dr Reddys Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Equivalents2.6 B2.8 B

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out the analysis of Dr Reddys Correlation against competitors.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.76
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.